Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)

SHE:002675 Revenue

Yantai Dongcheng Pharmaceutical Group had revenue of 682.55M CNY in the quarter ending June 30, 2026, a decrease of -2.04%. This brings the company's total for the last twelve months to 2.67B, down -5.85% year-over-year. In the year 2025, Yantai Dongcheng Pharmaceutical Group had annual revenue of 2.74B, down -4.46%. That makes Yantai Dongcheng Pharmaceutical Group the 12,564th largest company in the world by revenue and 2,172nd in China.

• Revenue (ttm): 2.67B
• Revenue Growth: -5.85%
• P/S Ratio: 3.94
• Revenue / Employee: 1.03M
• Employees: 2,583
• Market Cap: 10.58B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Radio Pharmaceutical Products 1.13B 40.2%
• API Related Products 1.03B 36.7%
• Preparatory Products 369.81M 13.2%
• Others 281.40M 10.0%

By Geography

Chart

• China 1.62B 59.3%
• Overseas 1.12B 40.7%

Fiscal year ended Dec 31, 2025 See the full SHE:002675 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.74B	-127.86M	-4.46%
Dec 31, 2024	2.87B	-406.71M	-12.42%
Dec 31, 2023	3.28B	-307.31M	-8.58%
Jan 1, 2023	3.58B	-329.09M	-8.41%
Jan 1, 2022	3.91B	493.07M	14.42%

Data Source: S&P Global Market Intelligence Last updated: Aug 21, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error